Blood pressure control and factors predicting control in a treatment-compliant male veteran population

被引:11
作者
Bizien, MD
Jue, SG
Panning, C
Cusack, B
Peterson, T
机构
[1] Mayo Clin, Ambulatory Care Pharm Serv, Rochester, MN 55905 USA
[2] Vet Affairs Med Ctr, Serv Pharm, Boise, ID USA
[3] Idaho State Univ, Dept Pharm Practice, Coll Pharm, Pocatello, ID 83209 USA
[4] Univ Wyoming, Dept Pharm Practice, Sch Pharm, Laramie, WY 82071 USA
[5] Med Serv, Dept Vet Affairs, Boise, ID USA
[6] Idaho State Univ, Coll Business, Pocatello, ID 83209 USA
来源
PHARMACOTHERAPY | 2004年 / 24卷 / 02期
关键词
hypertension; blood pressure; control; elderly; treatment; antihypertensives; compliant; simvastatin;
D O I
10.1592/phco.24.2.179.33136
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To estimate blood pressure control and identify treatment variables predicting control in treatment-compliant, hypertensive, male veterans. Setting. Outpatient clinic of a Veterans Affairs medical center. Design. Retrospective review of computerized patient records over a 12-month period for demographics, comorbidities, patient-specific blood pressure goals, blood pressure history, antihypertensive therapy, and refill history. Patients. Two hundred fifty hypertensive men aged 39-90 years whose antihypertensive regimen remained unchanged over 12 months. Measurements and Main Results. The proportion of patients with blood pressures below 160/90 mm Hg was 86%; only 34.8% had pressures below 140/90 mm Hg. Blood pressure control was less common with advancing age (42.1%, 33.7%, and 29.4% for patients aged < 60, 60-75, and > 75 yrs, respectively, p=0.057 for trend). Treatment intensity was highest in obese men, those aged 60-75 years, and those with a history of chronic heart failure or angina, and lowest in men older than 75 years or with a history of stroke. Blood pressure control was independently associated with therapy with beta-blockers (odds ratio [OR] 3.5, 95% confidence interval [CI] 1.5-10.2, p=0.005), loop diuretics (OR 4.3, 95% Cl 1.6-12.1, p=0.005), angiotensin-converting enzyme inhibitors (OR 3.1, 95% CI 1.2-8.2, p=0.025), and long-term simvastatin therapy (OR 3.7, 95% CI 1.9-7.4, p=0.0001), and with a diagnosis of coronary artery disease (OR 3.2, 95% Cl 1.35-7.69, p=0.009). The relationship between simvastatin therapy and blood pressure control persisted after controlling for the higher treatment intensity in patients taking the drug. Factors predicting poor control included a history of stroke (OR for control 0.36, 95% CI 0.19-0.69, p=0.002), age over 75 years (OR 0.43, 95% Cl 0.18-0.98, p=0.046), highest low-density lipoprotein tertile (OR 0.37, 95% CI 0.17-0.80, p=0.013), highest body mass index tertile (OR 0.46, 95% Cl 0.21-1.00, p=0.05), and therapy with two or fewer antihypertensives (OR 0.14, 95% Cl 0.04-0.61, P=0.009). Conclusion. In a compliant veteran population, control of blood pressure appeared inadequate but was significantly more likely in those receiving at least three antihypertensive agents. Long-term therapy with simvastatin was independently associated with increased odds of control.
引用
收藏
页码:179 / 187
页数:9
相关论文
共 27 条
[1]  
AMERY A, 1985, LANCET, V1, P1349
[2]   Inadequate management of blood pressure in a hypertensive population [J].
Berlowitz, DR ;
Ash, AS ;
Hickey, EC ;
Friedman, RH ;
Glickman, M ;
Kader, B ;
Moskowitz, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (27) :1957-1963
[3]   Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia [J].
Borghi, C ;
Prandin, MG ;
Costa, FV ;
Bacchelli, S ;
Degli Esposti, D ;
Ambrosioni, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (04) :549-555
[4]  
Borghi Claudio, 2002, J Clin Hypertens (Greenwich), V4, P277, DOI 10.1111/j.1524-6175.2002.00499.x
[5]   PREVALENCE OF HYPERTENSION IN THE US ADULT-POPULATION - RESULTS FROM THE 3RD NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1991 [J].
BURT, VL ;
WHELTON, P ;
ROCCELLA, EJ ;
BROWN, C ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D .
HYPERTENSION, 1995, 25 (03) :305-313
[6]  
Carter BL, 2002, PHARMACOTHERAPY PATH, P157
[7]   The effect of Enalapril on PGI2 and NO levels in hypertensive patients [J].
Di Girolamo, G ;
González, E ;
Livio, D ;
de los Santos, AR ;
Martí, ML ;
de Gimeno, MAF .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2002, 66 (5-6) :493-498
[8]   Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension [J].
Ferrier, KE ;
Muhlmann, MH ;
Baguet, JP ;
Cameron, JD ;
Jennings, GL ;
Dart, AM ;
Kingwell, BA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (06) :1020-1025
[9]  
GIFFORD RW, 1993, ARCH INTERN MED, V153, P154
[10]   Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia [J].
Glorioso, N ;
Troffa, C ;
Filigheddu, F ;
Dettori, F ;
Soro, A ;
Parpaglia, PP ;
Collatina, S ;
Pahor, M .
HYPERTENSION, 1999, 34 (06) :1281-1286